Inflection Point Genetics Inc. — Form D
Inflection Point Genetics Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-08. The offering totals $1.0M, of which $265K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-11-08
- Form: D
- Accession: 0001953599-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $265K
- Remaining: $735K
- Minimum investment: $15K
- Investors: 6
- Date of first sale: 2022-10-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-464185
Issuer
- Name: Inflection Point Genetics Inc.
- CIK: 0001953599
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 4340 DUNCAN AVENUE, ST. LOUIS, MO, 63110
- Phone: 314-615-6355
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Edward Weinstein | Director | St. Louis, MO |
| Edward Weinstein | Executive Officer | St. Louis, MO |
More